These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
727 related articles for article (PubMed ID: 8805637)
21. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation. Dang LH; Lien LL; Benacerraf B; Rock KL J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833 [TBL] [Abstract][Full Text] [Related]
22. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance. Guéry JC; Sette A; Appella E; Adorini L J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867 [TBL] [Abstract][Full Text] [Related]
23. Murine CD4+ T cells undergo TCR-activated adhesion to extracellular matrix proteins but not to nonantigenic MHC class II proteins. O'Rourke AM; Lasam MC J Immunol; 1995 Oct; 155(8):3839-46. PubMed ID: 7561090 [TBL] [Abstract][Full Text] [Related]
24. Major histocompatibility complex regulation of T helper functions mapped to a peptide C terminus that controls ligand density. Murray JS; Ferrandis-Edwards D; Wolfe CJ; Schountz T Eur J Immunol; 1994 Oct; 24(10):2337-44. PubMed ID: 7925562 [TBL] [Abstract][Full Text] [Related]
25. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide. Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792 [TBL] [Abstract][Full Text] [Related]
26. Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells. Farr A; DeRoos PC; Eastman S; Rudensky AY Eur J Immunol; 1996 Dec; 26(12):3185-93. PubMed ID: 8977321 [TBL] [Abstract][Full Text] [Related]
27. The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen. Thomas DB; Hodgson J; Riska PF; Graham CM J Immunol; 1990 Apr; 144(7):2789-94. PubMed ID: 1690778 [TBL] [Abstract][Full Text] [Related]
28. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells. Sant AJ J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935 [TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones. Mills KH Immunology; 1988 Nov; 65(3):365-71. PubMed ID: 2463222 [TBL] [Abstract][Full Text] [Related]
30. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice. Moreno J; Adorini L; Hämmerling GJ J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351 [TBL] [Abstract][Full Text] [Related]
31. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides. Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065 [TBL] [Abstract][Full Text] [Related]
32. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice. Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222 [TBL] [Abstract][Full Text] [Related]
33. BALB/c invariant chain mutant mice display relatively efficient maturation of CD4+ T cells in the periphery and secondary proliferative responses elicited upon peptide challenge. Kenty G; Bikoff EK J Immunol; 1999 Jul; 163(1):232-41. PubMed ID: 10384121 [TBL] [Abstract][Full Text] [Related]
34. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding. Lee JM; McKean DJ; Watts TH J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939 [TBL] [Abstract][Full Text] [Related]
35. Unexpected reactivities of T cells selected by a single MHC-peptide ligand. Singh N; Van Kaer L J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950 [TBL] [Abstract][Full Text] [Related]
36. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794 [TBL] [Abstract][Full Text] [Related]
37. The influence of invariant chain on the positive selection of single T cell receptor specificities. Tourne S; Nakano N; Viville S; Benoist C; Mathis D Eur J Immunol; 1995 Jul; 25(7):1851-6. PubMed ID: 7621862 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain. MacNeil D; Fraga E; Singh B Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364 [TBL] [Abstract][Full Text] [Related]
39. [Analysis of the allele specific Ag-binding site on murine class II MHC]. Kajino K Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675 [TBL] [Abstract][Full Text] [Related]
40. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Marzo AL; Lake RA; Robinson BW; Scott B Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]